Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 10,000 shares at $104.67 ($1.1M) on 2026-08-13, disclosed to the SEC on 2026-08-14.
Scheduled sale ($1.1M) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.67 | 2,100 | $220K | 20.6% |
| 2 | $105.57 | 2,132 | $225K | 21.1% |
| 3 | $106.63 | 1,268 | $135K | 12.7% |
| 4 | $107.71 | 2,142 | $231K | 21.6% |
| 5 | $108.46 | 2,358 | $256K | 24.0% |
| Total | $106.66 avg | 10,000 |
| $1.1M |
| 100% |
| Filing → |
| ORKA | SELL | 2026-07-13 | $846K | — | Filing → |
| ORKA | SELL | 2026-06-22 | $128K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $687K | — | Filing → |